- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06782672
Investigation of Objective Cognitive Effort in Neuropsychological Evaluation of Psychotic Disorders (INVESTIGECCO)
Psychotic disorders are characterised by a heterogeneity of symptoms, including cognitive disorders, which predict functional outcome. To date, the evaluation of cognitive functions essentially measures performance. Cognitive effort and the influence of psychological factors are rarely considered.
Based on the principle of energy conservation, the Motivational Intensity Theory (MIT) allows to test cognitive effort independently of performance, by measuring cardiovascular reactivity, as well as controlling for psychological factors (e.g., mood, fatigue, anxiety).
The main aim of this study is to investigate in a memory task the interaction between cognitive effort, performance and psychological factors in individuals with psychotic disorders compared to a non-clinical group, based on the predictions of the MIT.
This study will provide insights into the nature of cognitive impairment in psychotic disorders: primary or secondary to motivational (effort) or psychological (mood, fatigue, anxiety) difficulties.
Study Overview
Status
Detailed Description
The study will be proposed to patients with psychotic disorders (n=50) and non clinical participants (n = 50) aged 18 to 60.
This is a non-interventional, randomized, prospective experimental study with mixed design: 2 groups (psychotic disorders vs. non-clinical) with 2 repeated measures of difficulty (easy vs. difficult).
The study comprises a single visit with memory tests recording cardiovascular, and performance data, as well as participants' perceptions of the task (effort invested, difficulty, motivation to perform the task), followed by a psychological assessment using questionnaires and a semi-structured interview.
The study of these different measures (cardiovascular, performance, perception) will enable us to refine the understanding of cognitive deficits in psychotic disorders, taking psychopathological variables into account. will provide better direction for the care of this population: cognitive remediation for primary cognitive disorders vs. cognitive and behavioral therapies for cognitive disorders secondary to psychopathological variables (mood, fatigue, defeatist beliefs, motivational deficits).
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Amandine Décombe, PhD
- Phone Number: +33 0467332425
- Email: a-decombe@chu-montpellier.fr
Study Locations
-
-
-
Montpellier, France, 34295
- Montpellier University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Non-clinical group: Absence of any psychiatric disorder, community sample
Psychotic disorders group : Patients with a diagnosis within the schizophrenia spectrum and other psychotic disorders according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; APA, 2015), selected from the adult psychiatry department, inpatient or outpatient hospitalisation
Description
Inclusion Criteria in both groups
- Age ≥ 18 years and ≤60 years
Inclusion criteria for the psychotic disorders group:
- Patients with a diagnosis within the schizophrenia spectrum and other psychotic disorders according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; APA, 2015).
Inclusion criterion for the non-clinical group:
- Absence of any psychiatric disorder.
non-inclusion criteria in both groups
- Neurological disorder or history of head trauma;
- Cardiovascular disease or treatment for hypertension;
- Substance abuse or dependence disorder;
- Individuals who cannot understand or speak French;
- Non-affiliation with a social security system;
- Individuals participating in another study that includes an ongoing exclusion period;
- Individuals who have not provided written informed consent to participate in the study;
- Pregnant or breastfeeding women;
- Absence of written consent from the legal guardian for patients under guardianship;
- Absence of notification to the curator for patients under curatorship.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
psychotic disorders
The target population is people with a psychotic disorder (diagnosed as schizophrenia or schizoaffective disorder) according to DSM 5 criteria, aged between 18 and 60. The people with psychotic disorders recruited for this study are currently being cared for at the adult psychiatry department of Montpellier University Hospital. Participants will have a single visit with memory tests and data recording (cardiovascular, performance, perceptions), followed by a psychological assessment using questionnaires and a semi-structured interview. |
Measurement of pre-ejection period is the period between the onset of electrical excitation of the left ventricle and the opening of the aortic valve and heart rate will be continuous. These data will be collected using a cardiograph measuring the ECG signal and impedance cardiography (ICG). The system's four electrodes are positioned on the middle axillary line at the end of the sternum and at the base of the neck. Blood pressure measurements (PAS and PAD) will be taken from a cuff placed on the brachial artery of the non-dominant arm. cardiovascular values will be measured continuously:
The averages of the last 5 minutes during the resting period will constitute the resting values, and the averages of the 5 minutes of each difficulty level will constitute the values during cognitive effort. First, a quiet period with the viewing of a documentary film (8min). Then, participants will perform two 5-minute memory tasks of different difficulty levels (memorizing 3 letters corresponds to the easy level vs. 7 letters to the difficult level), separated by a 5-minute break. The order of difficulty will be counterbalanced. At the end of each difficulty level, self-report measures assessed by the following questions will be collected:
psychopathological measures collected using questionnaires:
|
|
non clinical, control
The non-clinical population should be similar to the psychotic disorders population in terms of age, level of education and gender. Participants will have a single visit with memory tests and data recording (cardiovascular, performance, perceptions), followed by a psychological assessment using questionnaires and a semi-structured interview. |
Measurement of pre-ejection period is the period between the onset of electrical excitation of the left ventricle and the opening of the aortic valve and heart rate will be continuous. These data will be collected using a cardiograph measuring the ECG signal and impedance cardiography (ICG). The system's four electrodes are positioned on the middle axillary line at the end of the sternum and at the base of the neck. Blood pressure measurements (PAS and PAD) will be taken from a cuff placed on the brachial artery of the non-dominant arm. cardiovascular values will be measured continuously:
The averages of the last 5 minutes during the resting period will constitute the resting values, and the averages of the 5 minutes of each difficulty level will constitute the values during cognitive effort. First, a quiet period with the viewing of a documentary film (8min). Then, participants will perform two 5-minute memory tasks of different difficulty levels (memorizing 3 letters corresponds to the easy level vs. 7 letters to the difficult level), separated by a 5-minute break. The order of difficulty will be counterbalanced. At the end of each difficulty level, self-report measures assessed by the following questions will be collected:
psychopathological measures collected using questionnaires:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interaction effect of group x difficulty on cardiovascular reactivity (Pre-Ejection Period - PEP)
Time Frame: 18 minutes
|
The difference score between the pre-ejection period (PEP) during the task (easy and difficult) and the PEP at rest (i.e., baseline), expressed in ms.
|
18 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Investigation of systolic blood pressure in both groups and difficulties
Time Frame: 18 minutes
|
expressed in mmHg
|
18 minutes
|
|
Investigation of diastolic blood pressure in both groups and difficulties
Time Frame: 18 minutes
|
expressed in mmHg
|
18 minutes
|
|
Investigation of heart rate pressure in both groups and difficulties
Time Frame: 18 minutes
|
expressed in beats/minutes
|
18 minutes
|
|
Comparison of correct performance
Time Frame: 10 minutes
|
The percentage of correct responses between the two groups and in both levels of difficulty
|
10 minutes
|
|
Comparison of errors
Time Frame: 10 minutes
|
The rate of errors between the two groups and in both levels of difficulty
|
10 minutes
|
|
Comparison of self-reported effort in both groups and both difficulties
Time Frame: 1 minute
|
Self-reported effort will assess through the following question: - "How much effort did you exert during the task?" Response will be on a Likert scale ranging from 1 ('Not at all effort') to 7 ('A lot of effort'). |
1 minute
|
|
Comparison of self-reported difficulty in both groups and both difficulties
Time Frame: 1 minute
|
Self-reported difficulty will assess through the following question: "How difficult did you find the task?" Response will be on a Likert scale ranging from 1 ('Very easy') to 7 ('Very difficult'). |
1 minute
|
|
Comparison of self-reported motivation in both groups and both difficulties
Time Frame: 1 minute
|
Self-reported motivation will assess through the following question: "How motivated were you to complete the task?" Response will be on a Likert scale ranging from 1 ('Not at all motivated') to 7 ('Very motivated'). |
1 minute
|
|
Influence of depressed mood on effort
Time Frame: 5 minutes
|
Beck Depression Inventory (BDI-II, Beck et al., 1996, internal consistency α = .92). This self-administered questionnaire consists of 21 items, each scored from 0 to 3. The total score ranges from 0 to 63. The higher the score, the more severe the depression. |
5 minutes
|
|
Influence of anxiety on effort
Time Frame: 5 minutes
|
State-Trait Anxiety Inventory (Form Y) (STAY-Y, Spielberger et al., 1983, Bruchon-Schweitzer & Paulhan, 1993 for French validation, internal consistency α = .91).
The STAY-Y assesses two scales momentary anxiety and trait anxiety, each comprising 20 items.
Scores range from 1 ("Not at all for the momentary anxiety scale, "Almost never" for the trait anxiety scale) to 4 ("A lot", "Almost always", respectively).
The higher the score, the more severe the anxiety.
|
5 minutes
|
|
Influence of fatigue on effort
Time Frame: 3 minutes
|
Multidimensional Fatigue Inventory, 20-item version (IMF-20, Smets et al., 1995, Gentille et al., 2003 for French validation, internal consistency α > .70).
This scale comprises 20 items ranging from 1 ("Strongly disagree") to 5 ("Strongly agree").The total score is between 4 and 20, the higher the score, the greater the fatigue felt.The MFI has 5 subscales: general fatigue, mental fatigue, reduced motivation, physical fatigue, reduced activities.
|
3 minutes
|
|
Influence of defeatist beliefs on effort
Time Frame: 3 minutes
|
General Self-Efficacy Scale (GSES, Schwarzer & Jerusalem, 1995, Dumont et al., 2000, for French validation, internal consistency α > .76).This scale measures feelings of self-efficacy .
This scale measures feelings of self-efficacy (the opposite of defeatist beliefs).
It comprises 10 items, scored on a Likert scale ranging from 1 ("Not at all true") to 4 ("Totally true").
The higher the score, the higher the sense of self-efficacy, and the lower the person's self-defeating beliefs.
|
3 minutes
|
|
Influence of negatives symptomes on effort in schizophrenia group
Time Frame: 30 minutes
|
Clinical Assessment Interview for Negative Symptoms (CAINS, Kring et al., 2013; Laraki et al., 2022 for French validation, internal consistency α = 0.87). This is a semi-structured interview assessing the negative symptoms of schizophrenia. This interview is composed of 13 items ranging from 0 (absence/no deficit) to 5 (severe deficit). The interview includes two subscales: motivation and pleasure (MAP, 9 items) and expressivity (EXP, 4 items). |
30 minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Amandine Décombe, PhD, University Hospital, Montpellier
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHLMPL23_0456
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychotic Disorders
-
Medical College of WisconsinCompletedSchizophrenia | Affective Disorders | Psychotic Disorder | Psychotic Mood Disorder
-
Søren Dinesen ØstergaardCompletedAffective Disorders, PsychoticDenmark
-
Instituto de Investigación Hospital Universitario...CompletedSchizophrenia and Disorders With Psychotic Feature | Psychotic EpisodeSpain
-
University of MinnesotaUniversity of California, San FranciscoCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | Cognitive Impairment | Psychosis | Treatment | Psychotic Depression | Psychotic Episode | Active Control | Psychotic Mood DisordersUnited States
-
University Hospital, CaenRecruiting
-
Philipp HomanRecruitingPsychotic DisorderCzechia, Ireland, Netherlands, Norway, Switzerland, Turkey (Türkiye)
-
Instituto de Investigación Hospital Universitario...Carlos III Health Institute; European Regional Development FundCompletedSchizophrenia and Disorders With Psychotic Features | Psychotic EpisodeSpain
-
Centre hospitalier de Ville-Evrard, FranceRecruiting
-
Natalia Dewi Wardani, MDIndonesian Red Cross; The Indonesian Red CrossCompleted
-
University Hospital, Strasbourg, FranceRecruiting
Clinical Trials on Cardiovascular measurements
-
University Hospital, CaenUnknown
-
University Hospital, CaenCompleted
-
University Health Network, TorontoRecruitingRespiratory Insufficiency | Lung Injury | Mechanical Ventilation Complication | Diaphragm Injury | Abdominal Muscle StrainedCanada
-
Aswan UniversityCompletedSex DeterminationEgypt
-
Essilor InternationalRecruiting
-
Mayo ClinicNot yet recruitingUlnar NerveUnited States
-
Marmara UniversityRecruitingCerebral Palsy | Infant, Premature, Diseases | Preterm Birth ComplicationTurkey
-
Kahramanmaras Sutcu Imam UniversityCompletedCerebral Palsy | Infant, Premature, Diseases | Neurologic Disorder | Infant, Newborn, Disease | Infant Development | Development Delay | Infant, Very Low Birth Weight | Infant, Small for Gestational Age | Infant AsphyxiaTurkey
-
Pamukkale UniversityCompletedDiabetes Mellitus, Type 2 | Periodontitis | Coronary Heart Disease | Arterial StiffnessTurkey